C/A 0001853657 XXXXXXXX 020-27868 LIVE false false false true See explanatory note following table of contents. Eysz, Inc. Corporation DE 05-31-2018 107 Sandringham Rd. Piedmont CA 94611 www.eyszlab.com N Bioverge Portal 0001737940 007-00157 005022636 The intermediary will receive a $10,000 setup fee and a commission equal to 5% of the gross proceeds of the offering. In addition, the intermediary will receive a commission equal to 2% of the securities sold in the offering under this offering statement. N/A Other Crowd SAFE 50000 1.00000 $1.00 50000.00 Y Other At the Company's discretion 1070000.00 09-29-2021 2.00 1349761.00 458558.00 1192495.00 406041.00 0.00 0.00 119486.00 72394.00 1374000.00 274000.00 123113.00 150000.00 -0.00 -0.00 -0.00 9564.00 -263018.00 61366.00 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC PR Eysz, Inc. /s/ Rachel Kuperman Founder and Chief Executive Officer /s/ Parth Amin Co-founder and Chief Operating Officer 04-08-2021 /s/ Randy Berholtz Director 04-08-2021